Skip to main content

Table 1 Baseline characteristics of children on HAART Treated in four ART # Centers in Addis Ababa, Ethiopia followed from 2005–2011

From: Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy

Characteristic Number (%)
Age  
 -≤ 11 months 46(3.9 )
 -11 to 34 169 (14.2)
 -34 to 59 212 (17.9)
 -≥60 month 759 (64)
Sex  
 -Female 608 (51.2%)
 -Male 578 (48.8%)
Duration of Follow up  
 -Less than one year 265(22.3)
 -One to two years 270(22.8)
 -Two to three years 248(20.9)
 -Three to four years 225(19.0)
 -More than four years 178(15.0)
Parental status  
 -Both alive 427(36.96)
 -Either dead 468(40.51)
 -Both dead 260(22.5)
 -Unknown 31 (2.6)
Serology of the care takers  
 -Positive 773(65.2)
 -Negative 55(4.6)
 -Unknown 358(30.2)
Primary care taker  
 -Both parents 415(35)
 -Mother 249(21)
 -Father 156(13.2)
 -Relatives 125(10.5)
 -Guardians /neighbors 142(12)
 -Orphange 99(8.3)
WHO stage  
 -I 42(3.5)
 -II 305(25.7)
 -III 626(52.8)
 -IV 213(18)
Weight –for- Age  
 -Below 3rd centile 172(14.5)
 ->3rd centile < 97th centile 192(16.2)
 -Above 97th centile 44(3.7)
 -Unknown 778 (65.6)
Height- for- Age  
 -Below 3rd centile 327(27.6)
 ->3rd centile < 97th centile 763(6.3)
 -Above 97th centile 81(6.8)
 -Unknown 15(1.3)
Weight- for –Height  
 -Below 3rd centile 105(8.9)
 ->3rd centile < 97th centile 245(20.7)
 -Above 97th centile 707(59.6)
 -Unknown 129(10.9)
Regimen started at initiation of ART  
 -4a (D4T + 3TC + NVP) 388(32.7)
 -4b(D4T + 3TC + EFV) 106(8.9)
 -4c(ZDV + 3TC + NVP) 300(25.3)
 -4d(ZDV + 3TC + EFV) 361(30.4)
Infant ART prophylaxis  
 -NVP 9(0.8)
 -NVP + ZDV 977(82.4)
 -None 977(82.4)
 -Unknown 181(15.3)
Immunosupression at initiation of ART $  
 -Not Significant 160(13.5)
 -Mild Immunosupression 145(12.2)
 -Advanced Immunosupression 331(27.9)
 -Severe Immunosupression 450(37.9)
 -Unknown 100(8.4)
Chronic Diarrhea after initiation  
 -Yes 16 (1.3)
 -None 1170(98.7)
  1. € Highly Active Antiretroviral Therapy # Antiretroviral Therapy $ Level of immunosupression is based on the Ethiopian National ART guideline [10].